Ignite Creation Date:
2024-05-06 @ 7:59 AM
Last Modification Date:
2024-10-26 @ 11:54 AM
Study NCT ID:
NCT02643303
Status:
COMPLETED
Last Update Posted:
2022-12-02
First Post:
2015-12-18
Brief Title:
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Sponsor:
Ludwig Institute for Cancer Research
Organization:
Ludwig Institute for Cancer Research
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor |
| Head and Neck Squamous Cell Carcinoma |
| Breast Cancer |
| Sarcoma |
| Merkel Cell Carcinoma |
| Cutaneous T-Cell Lymphoma |
| Melanoma |
| Renal Cancer |
| Bladder Cancer |
| Prostate Cancer |
| Testicular Cancer |